How bacteria adapt to stress in the gut environment
Understanding redox-regulated mechanisms of environmental adaptation in gastrointestinal symbionts
This study is looking at how a type of bacteria called Helicobacter pylori manages to survive in the tough environment of the human stomach, especially when faced with the body's defenses, and it aims to help us understand this relationship better, which could lead to new ways to treat related health issues.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Yale University NIH-funded |
| Lab location | 1 site (New Haven, United States) |
| Project ID | NIH-11089912 on NIH RePORTER |
What this research studies
This research investigates how gut bacteria, particularly Helicobacter pylori, adapt to oxidative stress in the human stomach. By using chemical and genetic tools, the study aims to uncover the molecular mechanisms that allow these bacteria to survive and thrive despite the challenges posed by the host's immune response. The research focuses on understanding how these bacteria sense environmental signals and respond to them, which is crucial for their symbiotic relationship with humans. The findings could lead to new insights into bacterial behavior and potential therapeutic strategies.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with chronic gastrointestinal conditions or infections related to Helicobacter pylori.
Not a fit: Patients with acute bacterial infections unrelated to gut microbiota or those without gastrointestinal issues may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could enhance our understanding of gut bacteria's role in health and disease, potentially leading to improved treatments for bacterial infections.
How similar studies have performed: Other research has shown success in understanding bacterial adaptation mechanisms, particularly in relation to oxidative stress, suggesting that this approach is promising.
Where this research is happening
New Haven, United States
- Yale University — New Haven, United States (Active)
Researchers
- Principal investigator: Hatzios, Stavroula — Yale University
- Study coordinator: Hatzios, Stavroula
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.